Eyebiotech Ltd.
Clinical trials sponsored by Eyebiotech Ltd., explained in plain language.
-
New eye drug aims to save sight for diabetics
Disease control OngoingThis study is testing if a new eye injection called EYE103 is safe and effective at treating diabetic macular edema (DME), a common cause of vision loss in people with diabetes. It will compare two doses of EYE103 against a standard treatment (ranibizumab) in over 1,000 participa…
Phase: PHASE2, PHASE3 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New eye injection trial aims to halt vision loss in common eye diseases
Disease control OngoingThis early-stage study is testing a new drug called EYE201, given as three injections into the eye, to see if it's safe and might help control vision loss. It's for adults with vision problems from diabetic macular edema, age-related macular degeneration, or a retinal vein blocka…
Phase: PHASE1, PHASE2 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:20 UTC